查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1854557

腎臟和泌尿系統器械市場：按產品、應用、最終用戶、技術和分銷管道分類 - 全球預測（2025-2032 年）

Nephrology & Urology Devices Market by Product, Application, End User, Technology, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，腎臟和泌尿系統器械市場規模將達到 404.2 億美元，複合年成長率為 11.12%。

主要市場統計數據
基準年 2024 173.8億美元
預計年份：2025年 193.6億美元
預測年份：2032年 404.2億美元
複合年成長率 (%) 11.12%

本文簡要說明了人口壓力、臨床需求和技術融合如何重塑腎臟病學和泌尿系統器械策略。

在全球腎臟病和泌尿系統醫療設備領域，人口結構變化、臨床需求和技術融合的驅動下，正經歷一場劇烈的創新和結構性變革。慢性腎臟病的流行持續影響透析治療的需求，而微創泌尿系統手術的進步正在重新定義腎結石、攝護腺疾病和尿失禁的治療標準。同時，醫療服務模式的轉變，包括居家護理、門診外科手術和數位化隨訪，正迫使製造商和供應商重新思考產品設計、分銷和支援服務。

投資者和臨床領導者不僅要考慮設備性能，還要考慮生命週期經濟效益、與數位平台的互通性以及影響產品上市時間的監管管道。隨著成本控制和基於價值的採購日益強化，供應商與醫院、透析中心和居家照護機構的關係越來越圍繞配套服務和基本契約。因此，對於希望在該領域實現永續差異化的相關人員而言，清晰了解臨床工作流程、患者偏好和支付方動態至關重要。

這項措施凸顯了報告的核心關注：不斷變化的臨床需求和技術發展軌跡如何與市場進入、供應鏈韌性和商業化策略相互交織。它也為更深入的分析奠定了基礎，包括市場區隔、區域動態和競爭趨勢，這些因素將在未來幾年推動科技的普及應用。

微創手術、居家照護和數位醫療的融合如何重塑產品設計、照護管道和商業化模式

腎臟病和泌尿系統醫療設備領域正經歷著技術、臨床和商業性三方面的變革，這些變革正在重塑產品生命週期和醫療服務管道。微創技術、雷射和聲波治療方法的進步提高了手術的精準度，同時縮短了恢復時間，促使醫院和門診手術中心優先選擇能夠最佳化手術效率和患者體驗的器械。同時，家庭透析治療和可攜式血液透析機系統的普及正在催生新的醫療模式，這些模式強調患者自主性和減輕醫療機構的負擔，這也影響著器械的設計，使其更加注重安全性、易用性和遠端監測功能。

整合感測器和連接功能的富數據設備能夠實現預測性維護、個人化治療和增強型臨床監測。遠端醫療整合和遠端患者監護不再是輔助功能，而是許多尋求持續護理的終端使用者的核心需求。能夠透過真實數據展示臨床結果並提供全面培訓和服務體系的製造商將擁有競爭優勢。

在商業方面，分銷管道正在不斷演變，直銷、專業分銷商和數位市場都發揮互補作用。醫療系統和支付者越來越關注每次治療的價值，這推動了對既能改善治療效果又能降低總醫療成本的醫療器材的需求。這些相互交織的趨勢迫使傳統製造商和新參與企業都加快創新週期，建立策略夥伴關係關係，並重新評估定價和服務模式，以期實現長期應用。

評估2025年美國關稅趨勢將如何重塑設備產品線的採購、製造佈局和商業談判。

預計2025年美國貿易政策的調整和關稅上漲正迫使製造商和供應鏈相關人員重新評估籌資策略、生產佈局和定價方式。關稅帶來的成本壓力可能會增加進口零件和成品的到岸成本，進而影響醫院、透析中心和經銷商的採購決策。為因應這項挑戰，各公司正在探索近岸外包、供應商多元化和加強垂直整合等策略，以保障淨利率並維持穩定的供應。

累積影響將因產品線而異。複雜的次組件和高重量比設備可能比耗材和散裝產品面臨不同的經濟影響。採購團隊可能會更專注於整體擁有成本，並尋求長期合約和替代採購方案以降低價格波動。同時，與生產轉移或新供應商資格認證相關的監管和物流複雜性可能會導致更長的前置作業時間和額外的資本支出。

從策略角度來看，擁有靈活生產能力和完善品質系統的公司能夠更好地吸收或抵消關稅帶來的成本變化，同時保持市場進入。與支付方和醫療系統合作，使報銷模式與成本結構的變化相適應，可以減少實施過程中的摩擦。此外，積極溝通供應鏈風險緩解措施並保持庫存計劃透明的公司，將更有能力在政策主導的市場動盪中維護客戶信心。

深入的細分分析，重點關注產品、應用、技術、終端用戶和通路動態，這將決定臨床和商業策略。

細分市場洞察揭示了因產品、應用、最終用戶、技術和分銷管道而異的細微需求促進因素，這些因素都會影響研發重點和市場策略。在產品細分方面，導管和輸尿管支架仍然是需求穩定的基本拋棄式，而內視鏡和體外碎石機則在微創介入治療已成為標準實踐的地區優先考慮。透析設備組值得特別關注，因為它包括連續性腎臟替代療法系統、血液透析機過濾器、血液透析機系統和腹膜透析系統。在血液透析機系統中，居家透析和中心透析之間的差異至關重要，這會影響自動化、安全連鎖和遠端監控等設備功能。

應用主導的細分明確了設備必須支援的臨床管道。腎衰竭管理包括連續性腎臟替代療法（CRRT）、血液透析機和腹膜透析，每種療法都有不同的臨床工作流程和資本投入。腎結石清除術區分體外震波碎石術和雷射碎石術，二者在資本投入和維護上也有差異。前列腺疾病和尿失禁的管理需要兼具診斷準確性和治療效果的設備，這通常需要泌尿系統和尿失禁科之間的協作。

終端使用者細分進一步細化了市場格局：門診手術中心、透析中心、居家照護機構和醫院各自擁有不同的採購流程、人員配備模式和臨床重點，這些因素決定了培訓、服務和資金籌措需求。技術細分則突顯了技術創新融合的領域——聲波、電化學、雷射和超過濾技術——並展示了這些技術如何廣泛應用於各種產品和應用需求。最後，分銷管道細分——直銷、分銷商和電子商務——影響著買家體驗和售後支援預期，其中數位化管道提高了透明度，並能更快地補充耗材。

美洲、歐洲、中東和非洲以及亞太地區在監管、報銷和基礎設施方面的差異將如何影響推廣管道和商業性優先事項。

區域動態對三大主要區域叢集（美洲、歐洲、中東和非洲以及亞太地區）的普及曲線、監管嚴格程度和商業模式有顯著影響。在美洲，成熟的醫療保健基礎設施和不斷擴展的居家醫療計劃推動了家庭血液透析機和數位化設備的普及。區域內不同司法管轄區之間的差異則體現在報銷模式和醫院採購方式上，這些差異會影響普及的時間和規模。

歐洲、中東和非洲地區（EMEA）的監管和報銷環境複雜多樣，醫療器材核准嚴格，且各地區採用不同的醫療技術評估路徑，這可能導致產品上市時間延長，但同時也為已證實具有臨床和成本效益的產品提供獎勵。在該地區的部分市場，公共預算的限制促使市場對具有明顯效率提升或可應用於門診病人的醫療設備的需求增加。此外，監管機構對病人安全和環境保護的重視也推動了對一次性產品轉變為可重複使用產品的生命週期評估以及循環經濟模式的關注。

亞太地區的特徵是醫療體系快速現代化，同時又有大量服務不足的病患群體。透析基礎設施和泌尿系統手術能力的投資正在不斷擴大，而官民合作關係和政府主導的舉措往往加速了技術的應用。面向該地區的製造商必須平衡成本驅動的採購需求與建立強大的服務網路以及製定符合當地文化習慣的病人參與策略的需求。在所有地區，本地臨床教育、經銷夥伴和供應鏈韌性都是成功進入市場並實現規模化發展的關鍵因素。

競爭動態：現有企業、利基創新者和以服務主導的策略如何塑造產品系列、夥伴關係和市場差異化

腎臟病和泌尿系統醫療設備的競爭動態複雜多樣，既有成熟的醫療技術巨頭，也有專注於特定療法和數位化復健的創新新興企業。市場領導企業利用其規模優勢，投資於整合設備、耗材和遠端監測的整合系統，並與透析中心和醫院建立穩固的服務關係。同時，一些專業公司則透過針對特定臨床問題和營運限制的創新產品實現差異化競爭，例如一次性內視鏡、先進的體外碎石技術和攜帶式家庭透析治療平台。

策略活動主要圍繞以下主題：整合策略性收購以填補產品組合缺口；與軟體和資料分析供應商合作，將設備產生的資料轉化為臨床洞見；以及投資本地生產或提升製造彈性，以支援快速推出。隨著客戶日益重視執行時間和可預測的耗材供應，供應鏈夥伴關係和卓越的服務正成為越來越重要的競爭優勢。能夠證明已完成臨床檢驗和監管應對力的新參與企業有可能顛覆傳統的採購週期，但如何擴大商業營運規模並贏得機構投資者的信任仍然是關鍵的執行挑戰。

最終，將差異化的臨床表現與全面的生命週期支援（培訓、維護、結果衡量）相結合的公司將最有希望贏得長期的客戶關係，而敏捷的創新者將透過解決臨床醫生和患者的具體痛點來贏得快速的市場認可。

為製造商和醫療保健提供者制定切實可行的策略性舉措，以協調創新、供應鏈韌性和服務主導的商業化，從而確保永續的市場優勢。

行業領導者應優先考慮一系列切實可行的舉措，以確保在快速變化的環境中實現臨床應用並保持營運韌性。首先，透過與臨床醫生共同設計設備，並融入遠端監控和易用性功能以減輕培訓負擔，使研發投資與實際臨床工作流程保持一致。其次，建立靈活的生產和供應網路，以降低關稅和地緣政治風險，並在保證品質和合規性的前提下，實現跨區域的快速生產分配。

第三，我們將拓展以服務為導向的經營模式，將資本設備與耗材、培訓和數位化監控結合，以創造差異化的價值提案和持續的收入來源。第四，我們將投資於可靠的真實世界證據項目和臨床夥伴關係，以產生支持報銷討論和採購決策的療效數據。第五，我們將根據終端用戶群調整市場推廣策略。例如，我們將優先在居家醫療環境中推廣易於使用的家庭透析治療系統，在醫療機構環境中推廣高通量、耐用的設備。

最後，制定多通路分銷策略，將複雜設備的直銷與耗材和小型設備的經銷商及電商通路結合，以增強商業靈活性。與客戶就供應鏈最佳化措施進行透明溝通，並制定反映整體醫療成本降低而非僅僅單位成本降低的定價策略。這些措施將提高市場應對力，減少實施阻力，並協助企業實現永續成長。

一種穩健的實證方法，結合了針對臨床醫生的原始研究、全面的二手研究和嚴格的數據三角驗證，以檢驗研究結果。

本分析的調查方法結合了定性研究、有針對性的二手研究以及嚴謹的三角驗證，以確保研究結果具有可操作性且以證據為依據。主要資料來源包括對臨床醫生、醫院和透析中心採購負責人、技術開發人員以及分銷合作夥伴進行結構化訪談，以獲取關於臨床需求、應用障礙和服務期望的第一手觀點。此外，還邀請了由執業腎臟科醫生和泌尿系統組成的顧問小組對這些訪談進行審查，以檢驗臨床相關性和手術趨勢。

二級研究深入檢視同行評審文獻、監管指令、臨床指南和公開白皮書，以確定臨床和技術背景。透過與供應商揭露資訊、產品註冊和專利狀態進行交叉驗證，整合市場狀況。定量和定性輸入資料進行三角驗證以減少偏差，並透過情境分析對關鍵假設進行壓力測試，重點關注供應鏈中斷、政策變化和技術採納率。

在整個過程中，資料品管包括來源檢驗、資料集一致性檢查和內部同行評審。當資料粒度受專有資訊或快速變更的政策環境限制時，我們會承認其局限性，並鼓勵隨著新證據的出現定期更新資料。

本文綜合分析了腎臟病和泌尿系統器械市場中，臨床、技術和商業性三大要素交會點所決定的成功因素。

總而言之，腎臟病和泌尿系統器械市場正處於曲折點，人口結構變化、臨床創新和不斷變化的醫療模式既帶來了機遇，也帶來了挑戰。居家和微創治療的興起推動了對以患者為中心設計、具備互聯性和易於維護的器械的需求。同時，商業性成功取決於能夠將可驗證的療效、供應鏈的靈活性和產品經濟效益與更廣泛的醫療保健價值目標相結合的經營模式。

投資於靈活製造、強大的臨床夥伴關係和完善的服務生態系統的相關人員將能夠克服監管差異和政策主導的成本壓力。按產品、應用、最終用戶、技術和分銷管道進行策略性細分，將有助於制定針對特定應用促進因素的客製化方案。最後，隨著醫療產業的現代化進程，就供應緩解措施和實際應用效果進行透明溝通，對於維護與醫療保健採購者和患者的信任仍然至關重要。

這些結論強調了整合策略的重要性，該策略應平衡技術創新、營運韌性和商業性適應性，以充分發揮腎臟病和泌尿系統醫療設備市場的潛力。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 人工智慧驅動的尿液生物標記分析平台可實現腎臟疾病的即時篩檢
  • 開發具有可控按需藥物釋放型性能的可生物分解輸尿管支架
  • 整合遠端醫療平台，用於遠距腹膜透析管理和病患教育
  • 採用3D列印患者特異性腎臟血管移植物進行複雜重組手術
  • 基於奈米顆粒的標靶藥物傳遞系統在多囊性腎病變治療的進展
  • 機器人輔助微創技術在複雜尿道結石和攝護腺手術的應用
  • 推出配備人工智慧超過濾和個人化治療功能的智慧家用血液透析機機
  • 應用預測分析技術最佳化連續性腎臟替代療法裝置的液體清除。
  • 拓展數位健康應用，用於移植後泌尿系統病患的監測與遵從性管理

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

第8章 腎臟和泌尿系統器械市場（按產品分類）

  • 導管
  • 透析設備
    • 連續性腎臟替代療法系統
    • 血液透析機過濾器
    • 血液透析機系統
      • 居家醫療
      • 中心設定
    • 腹膜透析系統
  • 內視鏡檢查
  • 碎石裝置
  • 輸尿管支架

9. 按應用分類的腎臟和泌尿系統器械市場

  • 腎衰竭管理
    • CRRT
    • 血液透析機
    • 腹膜透析
  • 腎結石清除
    • 體外震波碎石術
    • 雷射碎石術
  • 攝護腺疾病
  • 尿失禁管理

第10章 按最終用戶分類的腎臟和泌尿系統器械市場

  • 門診手術中心
  • 透析中心
  • 居家照護
  • 醫院

第11章 按技術分類的腎臟和泌尿系統器械市場

  • 聲波技術
  • 電化學技術
  • 雷射技術
  • 超過濾技術

第12章 腎臟及泌尿系統器械市場（依分銷管道分類）

  • 直銷
  • 經銷商
  • 電子商務

第13章：腎臟和泌尿系統器械市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 腎臟及泌尿系統器械市場（按類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國腎臟及泌尿系統器械市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Fresenius Medical Care AG & Co. KGaA
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Nipro Corporation
    • Asahi Kasei Corporation
    • Boston Scientific Corporation
    • Coloplast A/S
    • Teleflex Incorporated
    • Olympus Corporation
    • Cook Medical LLC
Product Code: MRR-F927BA462957

The Nephrology & Urology Devices Market is projected to grow by USD 40.42 billion at a CAGR of 11.12% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 17.38 billion
Estimated Year [2025] USD 19.36 billion
Forecast Year [2032] USD 40.42 billion
CAGR (%) 11.12%

A concise orientation to how demographic pressures, clinical demand, and technological convergence are reshaping nephrology and urology device strategies

The global landscape for nephrology and urology devices is undergoing a period of concentrated innovation and structural change driven by demographic pressures, clinical demand, and technological convergence. Chronic kidney disease prevalence continues to shape demand for dialysis modalities while advances in minimally invasive urologic procedures are redefining standards of care for kidney stones, prostate disorders, and urinary incontinence. Meanwhile, the shifting delivery models in healthcare-toward home-based therapies, ambulatory surgical care, and digitally enabled follow-up-are compelling manufacturers and providers to rethink product design, distribution, and support services.

Investors and clinical leaders must consider not only device performance but also lifecycle economics, interoperability with digital platforms, and regulatory pathways that influence product launch timing. As cost containment and value-based procurement intensify, supplier relationships with hospitals, dialysis centers, and home care providers are increasingly framed around bundled services and outcome-based contracting. Consequently, a clear understanding of clinical workflows, patient preferences, and payer dynamics is essential for stakeholders seeking durable differentiation in this sector.

This introduction frames the report's core focus on how evolving clinical needs and technological trajectories intersect with market access, supply chain resilience, and commercialization strategies. It sets the stage for deeper analyses on segmentation, regional dynamics, and the competitive plays that will drive adoption over the coming years.

How convergence of minimally invasive procedures, home-based therapies, and digital health is rewriting product design, care pathways, and commercialization models

The landscape of nephrology and urology devices is being transformed by an overlapping set of technological, clinical, and commercial shifts that are altering product life cycles and care pathways. Minimally invasive technologies and advances in laser and acoustic modalities are increasing procedural precision while reducing recovery times, prompting hospitals and ambulatory surgical centers to prioritize devices that optimize throughput and patient experience. Concurrently, the expansion of home-based dialysis and portable hemodialysis systems is unlocking new models of care that emphasize patient autonomy and reduced facility burden, which in turn influence device design for safety, ease of use, and remote monitoring.

Data-rich devices that integrate sensors and connectivity are enabling predictive maintenance, therapy personalization, and enhanced clinical oversight. Telehealth integration and remote patient monitoring are no longer auxiliary features but core expectations for many end-users seeking continuity of care. This shift to digitally augmented offerings is also changing commercialization strategies: manufacturers that can demonstrate clinical outcomes through real-world data and that provide comprehensive training and service ecosystems gain competitive advantage.

On the commercial front, distribution channels are evolving as direct sales, specialized distributors, and digital marketplaces each play complementary roles. Health systems and payers are increasingly focused on value per episode, driving demand for devices that lower total cost of care while improving outcomes. The intersection of these trends is forcing legacy manufacturers and new entrants alike to accelerate innovation cycles, form strategic partnerships, and re-evaluate pricing and service models to capture long-term adoption.

Assessing how the 2025 United States tariff trajectory will reshape sourcing, manufacturing footprints, and commercial negotiations across device product families

Anticipated tariff measures and trade policy shifts in the United States expected in 2025 are prompting manufacturers and supply-chain stakeholders to reassess sourcing strategies, production footprints, and pricing approaches. Tariff-driven cost pressures are likely to elevate the landed cost of imported components and finished devices, which will ripple through procurement discussions at hospitals, dialysis centers, and distributors. In response, companies are exploring nearshoring, supplier diversification, and increased vertical integration to protect margins and maintain predictable supply.

The cumulative impact will not be uniform across product families. Devices with complex subassemblies or high value-to-weight ratios will experience different economic effects than consumables or high-volume disposables. Procurement teams will intensify scrutiny of total cost of ownership and explore longer-term contracts or alternative sourcing arrangements to mitigate price volatility. At the same time, regulatory and logistical complexity associated with relocating production or qualifying new suppliers may extend lead times and require additional capital investment.

Strategically, firms with flexible manufacturing capabilities and robust quality systems will be better positioned to absorb or offset tariff-induced cost shifts while preserving market access. Collaboration with payers and health systems to align reimbursement models with altered cost structures can ease adoption friction. Moreover, companies that proactively communicate supply-chain risk mitigation and maintain transparent inventory planning will more effectively retain customer confidence during periods of policy-driven disruption.

Detailed segmentation analysis highlighting product, application, technology, end-user, and channel dynamics that determine clinical and commercial strategies

Segmentation insights reveal nuanced demand drivers that vary by product, application, end user, technology, and distribution channel, each influencing R&D focus and go-to-market strategy. Within product segmentation, Catheters and Ureteral Stents continue to be essential disposables with steady demand, while Endoscopes and Lithotripsy Devices are prioritized where minimally invasive interventions are standard practice. The Dialysis Devices group merits particular attention because it includes Continuous Renal Replacement Therapy systems, Hemodiafilters, Hemodialysis Systems, and Peritoneal Dialysis Systems; within Hemodialysis Systems, an important delineation exists between Home Settings and In-Center Settings, which affects device features such as automation, safety interlocks, and telemonitoring.

Application-driven segmentation underscores the clinical pathways that devices must support. Kidney Failure Management spans CRRT, Hemodialysis, and Peritoneal Dialysis, each with distinct clinical workflows and capital-intensity profiles. Kidney Stone Removal differentiates between Extracorporeal Shock Wave Lithotripsy and Laser Lithotripsy, leading to divergent capital equipment and maintenance considerations. Prostate Disorders and Urinary Incontinence Management demand devices that integrate diagnostic precision with therapeutic efficacy and often require coordinated care across urology and continence services.

End-user segmentation further refines market approach: Ambulatory Surgical Centers, Dialysis Centers, Home Care Settings, and Hospitals each present unique procurement processes, staffing models, and clinical priorities, which dictate training, service, and financing requirements. Technology segmentation highlights where innovation is concentrated, including Acoustic Wave Technologies, Electrochemical Technologies, Laser Technologies, and Ultrafiltration Technologies, and these modalities are unevenly distributed across product and application needs. Finally, distribution channel segmentation-comprising Direct Sales, Distributors, and Ecommerce-shapes buyer experience and post-sale support expectations, with digital channels increasing transparency and enabling faster replenishment for consumables.

How regional regulatory, reimbursement, and infrastructure differences across the Americas, Europe Middle East & Africa, and Asia-Pacific determine adoption pathways and commercial priorities

Regional dynamics shape adoption curves, regulatory rigor, and commercial models in meaningful ways across the three major geographic clusters of the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, mature healthcare infrastructure and expanding home-care initiatives are supporting growth in home hemodialysis adoption and digitally enabled device deployment, while procurement tends to emphasize lifecycle cost and proven clinical outcomes. Moving between jurisdictions within the region reveals differences in reimbursement models and hospital purchasing practices that influence timing and scale of adoption.

The Europe, Middle East & Africa complex presents a heterogeneous regulatory and reimbursement environment, where stringent device approvals and localized health technology assessment pathways can lengthen commercialization timelines but also reward demonstrable clinical and cost benefits. In some markets within this region, constrained public budgets push demand toward devices that offer clear efficiency gains or outpatient migration potential. The regulatory focus on patient safety and environmental stewardship also encourages single-use-to-reusable lifecycle evaluations and circular-economy considerations.

Asia-Pacific is characterized by a mix of rapidly modernizing healthcare systems and large, underserved patient populations. Investment in dialysis infrastructure and urology procedural capacity is expanding, and technology adoption is often accelerated by public-private partnerships and government-led initiatives. Manufacturers targeting this region must balance cost-sensitive procurement with the need for robust service networks and culturally tailored patient engagement strategies. Across all regions, localized clinical education, distribution partnerships, and supply-chain resilience are decisive factors for successful market entry and scaling.

Competitive dynamics showing how incumbents, niche innovators, and service-led strategies are shaping product portfolios, partnerships, and market differentiation

Competitive dynamics in nephrology and urology devices reflect a mix of established medtech incumbents, specialized device innovators, and agile emerging firms focused on niche therapies or digital habilitation. Market leaders are leveraging scale to invest in integrated systems that combine capital equipment, consumables, and remote monitoring, thereby creating sticky service relationships with dialysis centers and hospitals. Simultaneously, specialist companies are differentiating through targeted innovations-such as single-use endoscopes, advanced lithotripsy modalities, and compact home dialysis platforms-that address specific clinical pain points and operational constraints.

Strategic activity is concentrated around several themes: consolidation through strategic acquisitions to fill portfolio gaps; partnerships with software and data analytics providers to turn device-generated data into clinical insights; and investment in manufacturing flexibility to support regional production or rapid ramp-up. Supply-chain partnerships and service excellence are increasingly important competitive levers as customers prioritize uptime and predictable consumable supply. New entrants that can demonstrate clinical validation and regulatory readiness may disrupt traditional procurement cycles, but scaling commercial operations and establishing trust with institutional buyers remain significant execution challenges.

Ultimately, companies that combine differentiated clinical performance with comprehensive lifecycle support-training, maintenance, and outcome measurement-are best positioned to capture long-term customer relationships, while nimble innovators can win pockets of rapid adoption by solving specific clinician or patient pain points.

Actionable strategic initiatives for manufacturers and providers to align innovation, supply-chain resilience, and service-led commercialization for durable market advantage

Industry leaders should prioritize a set of actionable initiatives to secure clinical adoption and operational resilience in a rapidly evolving environment. First, align R&D investments with real-world clinical workflows by co-designing devices with clinicians and incorporating remote monitoring and usability features that reduce training burden. Second, build flexible manufacturing and supplier networks that permit rapid allocation of production across regions to mitigate tariff and geopolitical risk while maintaining quality and regulatory compliance.

Third, expand service-oriented business models that bundle capital equipment with consumables, training, and digital monitoring to create differentiated value propositions and recurring revenue streams. Fourth, invest in robust real-world evidence programs and clinical partnerships to generate outcome data that supports reimbursement discussions and procurement decisions. Fifth, tailor go-to-market approaches by end-user segment; for example, prioritize user-friendly home dialysis systems for home care settings and high-throughput, durable devices for in-center use.

Finally, strengthen commercial agility by developing multi-channel distribution strategies that combine direct sales for complex capital equipment with distributor and e-commerce channels for consumables and smaller devices. Cultivate transparent communications with customers about supply-chain mitigation, and design pricing strategies that reflect total cost of care improvements rather than unit price alone. Together, these actions will enhance market responsiveness, reduce adoption friction, and position organizations for sustainable growth.

A robust evidence-based approach combining primary clinician insights, comprehensive secondary research, and rigorous data triangulation to validate findings

The research methodology underpinning this analysis combines primary qualitative engagement, targeted secondary research, and rigorous triangulation to ensure findings are actionable and evidence-based. Primary inputs include structured interviews with clinicians, procurement leaders at hospitals and dialysis centers, technology developers, and distribution partners to capture firsthand perspectives on clinical needs, adoption barriers, and service expectations. These interviews are supplemented by advisory panel reviews with practicing nephrologists and urologists to validate clinical relevance and procedural trends.

Secondary research encompasses a thorough review of peer-reviewed literature, regulatory agency directives, clinical guidelines, and public-domain white papers to establish clinical and technological context. Market intelligence is then synthesized through cross-validation with supplier disclosures, product registrations, and patent landscapes where appropriate. Quantitative and qualitative inputs are triangulated to reduce bias, and key assumptions are stress-tested through scenario analysis focusing on supply-chain disruptions, policy shifts, and technology adoption rates.

Throughout the process, data quality controls include source verification, consistency checks across datasets, and internal peer reviews. Limitations are acknowledged where data granularity is constrained by proprietary information or rapidly evolving policy environments, and recommendations emphasize areas for periodic updates as new evidence emerges.

Concluding synthesis of the intersecting clinical, technological, and commercial imperatives that define success in nephrology and urology device markets

In summation, the nephrology and urology devices landscape is at an inflection point where demographic pressures, clinical innovation, and shifting care models converge to create both opportunity and complexity. The transition toward home-based therapies and minimally invasive interventions increases demand for devices that prioritize patient-centric design, connectivity, and simplified serviceability. At the same time, commercial success will hinge on demonstrable outcomes, supply-chain agility, and business models that align product economics with broader healthcare value objectives.

Stakeholders who invest in flexible manufacturing, strong clinical partnerships, and comprehensive service ecosystems will be better positioned to navigate regulatory variation and policy-driven cost pressures. Strategic segmentation-by product, application, end user, technology, and distribution channel-enables tailored approaches that address specific adoption drivers. Finally, transparent communication around supply mitigation and real-world performance will remain essential to maintaining trust with institutional buyers and patients as the sector modernizes.

These conclusions underscore the importance of an integrated strategy that balances innovation with operational resilience and commercial adaptability to capture the full potential of nephrology and urology device markets.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Artificial intelligence-driven urine biomarker analysis platforms enabling real-time kidney disease screening
  • 5.2. Development of biodegradable ureteral stents with controlled on-demand drug elution properties
  • 5.3. Introduction of wearable continuous renal function monitors for early chronic kidney disease detection
  • 5.4. Integration of telemedicine platforms in remote peritoneal dialysis management and patient coaching
  • 5.5. Adoption of 3D printed patient-specific renal vascular grafts for complex reconstructive procedures
  • 5.6. Advances in nanoparticle-based targeted drug delivery systems for polycystic kidney disease therapy
  • 5.7. Deployment of robotic-assisted minimally invasive technologies in complex urolithiasis and prostate surgeries
  • 5.8. Emergence of smart home hemodialysis devices with AI-powered ultrafiltration and treatment personalization
  • 5.9. Implementation of predictive analytics in continuous renal replacement therapy machines to optimize fluid removal
  • 5.10. Expansion of digital health applications for post-transplant urological patient monitoring and compliance management

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nephrology & Urology Devices Market, by Product

  • 8.1. Catheters
  • 8.2. Dialysis Devices
    • 8.2.1. CrRt Systems
    • 8.2.2. Hemodiafilters
    • 8.2.3. Hemodialysis Systems
      • 8.2.3.1. Home Settings
      • 8.2.3.2. In-Center Settings
    • 8.2.4. Peritoneal Dialysis Systems
  • 8.3. Endoscopes
  • 8.4. Lithotripsy Devices
  • 8.5. Ureteral Stents

9. Nephrology & Urology Devices Market, by Application

  • 9.1. Kidney Failure Management
    • 9.1.1. CrRt
    • 9.1.2. Hemodialysis
    • 9.1.3. Peritoneal Dialysis
  • 9.2. Kidney Stone Removal
    • 9.2.1. Extracorporeal Shock Wave Lithotripsy
    • 9.2.2. Laser Lithotripsy
  • 9.3. Prostate Disorders
  • 9.4. Urinary Incontinence Management

10. Nephrology & Urology Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Dialysis Centers
  • 10.3. Home Care Settings
  • 10.4. Hospitals

11. Nephrology & Urology Devices Market, by Technology

  • 11.1. Acoustic Wave Technologies
  • 11.2. Electrochemical Technologies
  • 11.3. Laser Technologies
  • 11.4. Ultrafiltration Technologies

12. Nephrology & Urology Devices Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Ecommerce

13. Nephrology & Urology Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Nephrology & Urology Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Nephrology & Urology Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Fresenius Medical Care AG & Co. KGaA
    • 16.3.2. Baxter International Inc.
    • 16.3.3. B. Braun Melsungen AG
    • 16.3.4. Nipro Corporation
    • 16.3.5. Asahi Kasei Corporation
    • 16.3.6. Boston Scientific Corporation
    • 16.3.7. Coloplast A/S
    • 16.3.8. Teleflex Incorporated
    • 16.3.9. Olympus Corporation
    • 16.3.10. Cook Medical LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NEPHROLOGY & UROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. NEPHROLOGY & UROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NEPHROLOGY & UROLOGY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY IN-CENTER SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY IN-CENTER SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY IN-CENTER SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY IN-CENTER SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY IN-CENTER SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY IN-CENTER SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MI